Cargando…
Effect of serotonin modulating pharmacotherapies on body mass index and dysglycaemia among children and adolescents: a systematic review and network meta-analysis protocol
INTRODUCTION: Serotonin-modulating medications are commonly prescribed for mental health issues. Currently, there is limited consensus on weight gain and dysglycaemia development among children using these medications. The objective of this study is to review and synthesise all the available evidenc...
Autores principales: | Al Khalifah, Reem A, De Long, Nicole E, Florez, Ivan D, Mbuagbaw, Lawrence, Morrison, Katherine M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800145/ https://www.ncbi.nlm.nih.gov/pubmed/26983945 http://dx.doi.org/10.1136/bmjopen-2015-009998 |
Ejemplares similares
-
Simulated distributions from negative experiments highlight the importance of the body mass index distribution in explaining depression–body mass index genetic risk score interactions
por: Casanova, Francesco, et al.
Publicado: (2022) -
Insulin degludec/liraglutide (IDegLira) was effective across a range of dysglycaemia and body mass index categories in the DUAL V randomized trial
por: Lingvay, Ildiko, et al.
Publicado: (2017) -
Rethinking the syndemic of tuberculosis and dysglycaemia: a Kenyan perspective on dysglycaemia as a neglected risk factor for tuberculosis
por: Kerama, Cheryl, et al.
Publicado: (2023) -
Self-reported health and smoking status, and body mass index: a case-control comparison based on GEN SCRIP (GENetics of SChizophRenia In Pakistan) data
por: Ayub, Muhammad, et al.
Publicado: (2021) -
Critical illness-induced dysglycaemia: diabetes and beyond
por: Smith, Fang Gao, et al.
Publicado: (2010)